Figure 2From: Differential effects of simvastatin on IL-13-induced cytokine gene expression in primary mouse tracheal epithelial cellsSimvastatin inhibits Monocyte Chemotactic Protein (MCP) gene expression in mouse primary tracheal epithelial cells. Mouse primary tracheal epithelial cells grown in air-liquid interface (ALI) were pre-treated with simvastatin (Sim, 10 μM) for 24 hrs, then stimulated with IL-13 (20 ng/mL) and co-incubated with Sim for 48 hrs (total Sim exposure of 72 hrs). Gene expression was evaluated by RT-PCR. (A) Sim reduced IL-13-induced MCP-1 (CCL2) expression by 84.0% (*p < 0.005 for control vs. IL-13, and **p < 0.005 for IL-13 vs. IL-13 + Sim; both by ANOVA). Simvastatin treatment had no statistically significant inhibition of basal MCP-1 expression (Con. versus Sim 10 μM; p = NS by ANOVA). (B) Sim reduced IL-13-induced MCP-2 (CCL8) expression by 53.7% (*p < 0.05 for control vs. IL-13, and p = NS for IL-13 vs. IL-13 + Sim by ANOVA or t-test). Simvastatin treatment did not inhibit the basal expression of MCP-2 (Con. versus Sim 10 μM; p = NS by ANOVA). (C) Sim reduced IL-13-induced MCP-3 (CCL7) expression by 87.2% (*p < 0.05 for control vs. IL-13, and **p < 0.05 for IL-13 vs. IL-13 + Sim; both by ANOVA). Simvastatin treatment did not inhibit the basal expression of MCP-3 (Con. versus Sim 10 μM; p = NS by ANOVA)Back to article page